MENACTRA

Diphtheria Toxoid Conjugate VaccineMenactra is a vaccine designed to protect against meningococcal disease, a serious bacterial infection caused by Neisseria meningitidis. This infection can lead to meningitis, an inflammation of the protective membranes covering the brain and spinal cord, as well as septicemia, a life-threatening bloodstream infection. Meningococcal disease can progress rapidly and is potentially fatal, making vaccination crucial, especially for those at higher risk.Menactra ®,

• ✓Meningococcal ACYW-135 conjugate vaccine by Sanofi conjugated to diphtheria toxoid
• ✓Single-dose protection against meningitis and life-threatening bloodstream infections
• ✓Approved for individuals aged 2 years and above including adolescents and adults
• ✓Widely recommended for travelers to meningococcal-endemic regions